Severe edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase-4 inhibitor

被引:0
|
作者
Maita, Hiroki [1 ]
Kobayashi, Tadashi [2 ]
Akimoto, Takashi [2 ]
Osawa, Hiroshi [2 ]
Kato, Hiroyuki [1 ,2 ,3 ]
机构
[1] Hirosaki Univ, Dev Community Healthcare, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Dept Gen Med, Sch Med Hosp, Aomori, Japan
[3] Hirosaki Univ, Gen Med, Grad Sch Med, Aomori, Japan
来源
JOURNAL OF GENERAL AND FAMILY MEDICINE | 2022年 / 23卷 / 02期
关键词
blister; dipeptidyl peptidase-4 inhibitor; edema; sitagliptin;
D O I
10.1002/jgf2.502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:124 / 125
页数:2
相关论文
共 50 条
  • [21] Sensitive Spectrofluorimetric Methods for Determination of Sitagliptin Phosphate, Dipeptidyl Peptidase-4 Inhibitor, in Pharmaceutical Tablets and Spiked Human Urine
    Ali, Marwa F. Bakr
    Atia, Noha N.
    CURRENT PHARMACEUTICAL ANALYSIS, 2018, 14 (05) : 483 - 490
  • [22] Immunohistochemical, apoptotic and biochemical changes by dipeptidyl peptidase-4 inhibitor-sitagliptin in type-2 diabetic rats
    Sezin Karabulut
    Zeynep Mine Coskun
    Sema Bolkent
    Pharmacological Reports, 2015, 67 : 846 - 853
  • [23] Immunohistochemical, apoptotic and biochemical changes by dipeptidyl peptidase-4 inhibitor-sitagliptin in type-2 diabetic rats
    Karabulut, Sezin
    Coskun, Zeynep Mine
    Bolkent, Sema
    PHARMACOLOGICAL REPORTS, 2015, 67 (05) : 846 - 853
  • [24] Dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates inflammation and autophagy in mice hindlimb ischemia-reperfusion injury
    Mohammed, Marwa Abdeltawab
    Mohamed, Dalia Abdel-Wahab
    Zeid, Asmaa A. Abo
    Abdelmalak, Marian F. L.
    Mohamed, Maha Tarek
    Abdelrahim, Dina Sayed
    BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2024, 13 (01)
  • [25] A concise review of the bioanalytical methods for the quantitation of sitagliptin, an important dipeptidyl peptidase-4 (DPP4) inhibitor, utilized for the characterization of the drug
    Suresh, P. S.
    Srinivas, Nuggehally R.
    Mullangi, Ramesh
    BIOMEDICAL CHROMATOGRAPHY, 2016, 30 (05) : 749 - 771
  • [26] The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers
    Trocha, Malgorzata
    Nowak, Beata
    Merwid-Lad, Anna
    Szuba, Andrzej
    Dziegiel, Piotr
    Pisniewska, Malgorzata
    Gomulkiewicz, Agnieszka
    Wisniewski, Jerzy
    Piasecki, Tomasz
    Gziut, Magdalena
    Szelag, Adam
    Sozanski, Tomasz
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (11): : 1483 - 1490
  • [27] The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Protects against Dyslipidemia-Related Kidney Injury in Apolipoprotein E Knockout Mice
    Li, Jingjing
    Guan, Meiping
    Li, Chenzhong
    Lyv, Fuping
    Zeng, Yanmei
    Zheng, Zongji
    Wang, Chengzhi
    Xue, Yaoming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (07) : 11416 - 11434
  • [28] Comparative Activity of Proline-Containing Dipeptide Noopept and Inhibitor of Dipeptidyl Peptidase-4 Sitagliptin in a Rat Model of Developing Diabetes
    Ostrovskaya, R. U.
    Ozerova, I. V.
    Gudascheva, T. A.
    Kapitsa, I. G.
    Ivanova, E. A.
    Voronina, T. A.
    Seredenin, S. B.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 156 (03) : 342 - 346
  • [29] Long-term safety, tolerability, and efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes
    Odawara M.
    Kadowaki T.
    Tajima N.
    Nishii M.
    Taniguchi T.
    Ferreira J.C.A.
    Diabetology International, 2011, 2 (2) : 94 - 105
  • [30] Comparative Activity of Proline-Containing Dipeptide Noopept and Inhibitor of Dipeptidyl Peptidase-4 Sitagliptin in a Rat Model of Developing Diabetes
    R. U. Ostrovskaya
    I. V. Ozerova
    T. A. Gudascheva
    I. G. Kapitsa
    E. A. Ivanova
    T. A. Voronina
    S. B. Seredenin
    Bulletin of Experimental Biology and Medicine, 2014, 156 : 342 - 346